| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/17/2008 | EP1968595A2 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 09/17/2008 | EP1968576A1 Mif inhibitors |
| 09/17/2008 | EP1968566A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 09/17/2008 | EP1539128B1 Use of skin-protecting substances |
| 09/17/2008 | EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2008 | EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients |
| 09/17/2008 | EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 09/17/2008 | EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof |
| 09/17/2008 | EP1202736B1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/17/2008 | CN101267812A Hydrazone agents to treat cutaneous lesions |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264321A Use of transglutaminase |
| 09/17/2008 | CN101264309A Chinese medicine composition for treating alopecia |
| 09/17/2008 | CN101264288A Orally-administered Chinese medicine for treating psoriasis and preparation thereof |
| 09/17/2008 | CN101264287A Orally-administered Chinese medicine for treating acne and preparation thereof |
| 09/17/2008 | CN101264261A Chinese medicine for treating pruritus and preparation thereof |
| 09/17/2008 | CN101264248A Mattress for preventing and treating bedsore |
| 09/17/2008 | CN101264240A Externally-applied medicaments for treating tinea pedis |
| 09/17/2008 | CN101264196A Externally-applied medicinal composition for treating surgical wound and preparation of ointment thereof |
| 09/17/2008 | CN101264194A Chinese medicinal composition for treating traumatism |
| 09/17/2008 | CN101264178A Preparation of Chinese medicine lotion for treating malignant skin ulcer |
| 09/17/2008 | CN101264168A Product with beauty treatment and health care efficacy and preparation thereof |
| 09/17/2008 | CN101264165A Chinese medicine with anti-inflammation and itching-relieving action and preparation thereof |
| 09/17/2008 | CN101264139A Chinese medicine compound with menstruation-regulating and speckle-dispelling action and preparation thereof |
| 09/17/2008 | CN101264138A Method for processing calculus bovis bacteriostatic lotion |
| 09/17/2008 | CN101264135A Biological sterilization preparations |
| 09/17/2008 | CN101264130A Film coating agent for treating skin ulcer |
| 09/17/2008 | CN101264117A Mugwort flavone extracting technique and uses thereof |
| 09/17/2008 | CN101264104A Calf serum de-protein injection and producing method thereof |
| 09/17/2008 | CN101264102A Alkaline sxidative externally-applied medicaments for treating skin disease |
| 09/17/2008 | CN101264099A Medicaments for treating acne rosacea, comedo and acne |
| 09/17/2008 | CN101264075A Application of 2í», 5, 6í», 7-tetrahydroxy dihydroflavonol and its derivative for treating sepsis |
| 09/17/2008 | CN101264070A Dermatosis-treating medicine and preparation thereof |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418565C Chinese herbal liquor for treating manus tenea, pedes tenea, onychomycosis and its preparation process |
| 09/17/2008 | CN100418547C Multiflower knotweed tuber prepared product and its preparing method |
| 09/17/2008 | CN100418541C Nanometer antibiotic human body lubricant |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/17/2008 | CN100418513C Standby agent for treating burns |
| 09/17/2008 | CN100418509C Fine oil added skin-care product |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425356 Liquid crystalline polymers mixture:, display, optics, diagnosis |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425319 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2384448C Method of treatment of seborrheic dermatitis |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2376193C Therapeutic agent comprising a botulinum neurotoxin |
| 09/16/2008 | CA2339290C Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 09/16/2008 | CA2287477C Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| 09/16/2008 | CA2166062C The use of non-ionic surfactants in stable topical retinoid compositions |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/12/2008 | WO2008108309A1 Fused pyridine derivative |
| 09/12/2008 | WO2008107544A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof |
| 09/12/2008 | WO2008107099A1 Drug comprising at least one gestagen |
| 09/12/2008 | WO2008106983A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2008106966A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2008062324A3 Compositions comprising nicotinamide and wakame extract having skin anti-aging properties |
| 09/11/2008 | US20080221212 Diclofenac or salt; and penetration enhancer comprising N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate and sodium lauryl sulfoacetate; transdermal; cosmetics; skin disorders |
| 09/11/2008 | US20080221209 Psoriasis, alopecia, contact dermatitis, atopic dermatitis, allergies, vitiligo or inflammatory skin disorders; esterification reaction of oleyl alcohol and a stereoisomer of phenylglycine chloride hydrochloride in a polar aprotic solvent |
| 09/11/2008 | US20080221207 Use of specific cyklolignans |
| 09/11/2008 | US20080221200 Dipeptidyl-peptidase (DPP) IV inhibitor N-peptidyl-O-aroyl hydroxylamine and immunosuppressor or immunomodulator; autoimmune diseases, graft rejection; antidiabetic agents; Alzheimer's, Parkinson's disease; obesity, retinopathy, nephropathy, neuropathy, schizophrenia; cognition activators |
| 09/11/2008 | US20080221189 Rosacea, psoriasis, acute inflammation, chronic inflammation, septic shock, an autoimmune disease |
| 09/11/2008 | US20080221165 Use of Octenidine Dihydrochloride in Semisolid Preparations |
| 09/11/2008 | US20080221129 New compounds |
| 09/11/2008 | US20080221123 geranylgeranyltransferase I inhibitors; treatment of neoplasia, hyperproliferative cell growth, psoriasis, intimal hyperplasia (restinosis) and chronic inflammatory diseases including rheumatoid and osteoarthritis |
| 09/11/2008 | US20080221115 amino-phenyl-acetic acid octadec-(Z)-9-enyl ester HCl and piperazin-1-yl acetic acid octadec-(Z)-9-enyl ester bitartrate; topical; non-steroidal |
| 09/11/2008 | US20080221096 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221071 Comprises lumisterol and tachysterol, for topical administration |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220091 Reduction of reactive oxygen species in chronic wound management |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | DE202008009382U1 Zubereitungen als Pharmazeutika, Desinfektionsmittel, Hautpflege- und Hygienemittel oder Wundtherapeutika Preparations as pharmaceuticals, disinfectants, skin care and hygiene products or wound therapeutics |
| 09/11/2008 | DE10340417B4 Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion |
| 09/11/2008 | DE102007011486A1 Arzneimittel umfassend wenigstens ein Gestagen A pharmaceutical composition comprising at least one progestin |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967208A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 09/10/2008 | EP1967201A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 09/10/2008 | EP1966202A1 Heteroaryl substituted pyrroloý2,3-b¨pyridines and pyrroloý2,3-b¨pyrimidines as janus kinase inhibitors |
| 09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
| 09/10/2008 | EP1966156A2 New compounds iii |